SAVA - Class Action Lawsuit Filed Against Cassava Sciences Inc. (SAVA) on Behalf of Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer LLC Encourages Investors With Significant Losses to Contact the Firm | Benzinga

ATLANTA, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or "the Company") (NASDAQ:SAVA). The lawsuit alleges Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding its business, operations, and compliance policies, including allegations that: (i) the Company failed to maintain adequate and effective data management controls and procedures related to its drug research programs; (ii) as a result, the data published in support of simufilam were susceptible to manipulation to overstate the drug's effectiveness; (iii) ...

SAVA) on Behalf of Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm>Full story available on Benzinga.com